COMPARATIVE STUDY OF HAEMORRHOIDAL SUPPOSITORY FROM MODERN AND AYURVEDIC VIEW

Randomized control clinical study to evaluate the efficacy of Arshoghnivarti and Corect Suppository in Hemorrhoids.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/12/038798

Enrollment

100

Registered

2021-12-21

Start date

Unknown

Completion date

Unknown

Last updated

2022-02-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K642- Third degree hemorrhoids

Interventions

Intervention1: ARSHOGHNIVARTI: ONE SUPPOSITARY PER RECTAL TWICE A DAY GHUTA LUBRICATION FOR 15 DAYS Control Intervention1: CORECT SUPPOSITARY: ONE SUPPOSITARY PER RECTAL TWICE A DAY FOR 15 DAYS

Eligibility

Inclusion criteria

Inclusion criteria: PATIENTS DIAGNOSED WITH FIRST, SECOND AND THIRD DEGREE OF HEMORRHOIDES.

Exclusion criteria

Exclusion criteria: PATIENTS WITH 4TH DEGREE OF HEMORRHOIDES. KNOWN CASE OF D.M,HTN,LIVER DISEASES OR MALIGNANCY. PATIENTS DIAGNOSED WITH FISSURTE IN ANO. PATIENT WITH CA RECTUM. PREGNANT AND LACTATING WOMAN. PATIENT WITH HEMOGLOBIN BELOW 8 GM.

Design outcomes

Primary

Measure	Time frame
To evaluate the efficacy of Arshoghnivarti against Corect suppository in Hemorrhoids.Timepoint: 15 days	—

Secondary

Measure	Time frame
To study adverse effects of Arshoghnivarti and of Corect suppository if any.Timepoint: 15 days	—

Countries

India

Contacts

Public ContactSandeep Tanaji Nikam

PDEAs College of Ayurveda and research centre

dr.madhavibanarase209@gmail.com9423207569

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026